Compare IMRX & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMRX | HRZN |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.1M | 295.1M |
| IPO Year | 2021 | 2010 |
| Metric | IMRX | HRZN |
|---|---|---|
| Price | $4.93 | $6.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $17.20 | $7.13 |
| AVG Volume (30 Days) | ★ 1.2M | 891.4K |
| Earning Date | 03-19-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 19.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $98,899,000.00 |
| Revenue This Year | N/A | $2.84 |
| Revenue Next Year | N/A | $12.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $5.71 |
| 52 Week High | $10.08 | $9.99 |
| Indicator | IMRX | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 47.13 | 45.84 |
| Support Level | $4.86 | $6.42 |
| Resistance Level | $5.15 | $6.71 |
| Average True Range (ATR) | 0.31 | 0.12 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 60.98 | 34.25 |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.